WBRT & Erlotinib in Advanced NSCLC and Brain Metastases (TACTIC)

This study has been terminated.
(IDMC made a recommendation to stop the trial as the target for continuing to the 2nd phase was not met.)
Sponsor:
Collaborators:
Cancer Research UK
Roche Pharma AG
Information provided by (Responsible Party):
University College, London
ClinicalTrials.gov Identifier:
NCT00554775
First received: November 6, 2007
Last updated: December 9, 2011
Last verified: December 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)